Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term, multicenter trial of SPP-004 in mitochondrial diseases (MRCD Long-term Study)
jRCT2091220214Completed
- Sponsor
- Saitama Medical University Hospital
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid hydrochloride + sodium ferrous citrate in Mitochondriopathy, sponsored by Saitama Medical University Hospital. Primary endpoint: Newcastle Paediatric Mitochondrial Disease Scale Sections I–III. Started May 2015; status: completed.
02
Drugs
5-aminolevulinic acid hydrochloride + sodium ferrous citrate
03
Conditions
Mitochondriopathy
Beyond the preview
Go deeper on jRCT2091220214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220214.